Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
Clinical trial NCT00968526 · COMPLETED
Trial details
- NCT number
- NCT00968526
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-08
- Primary completion
- 2010-09-23
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.